Based on insights from member pharmacies that serve as the front lines of healthcare delivery, the National Association of Chain Drug Stores (NACDS) has submitted extensive and thoroughly documented comments to the Centers for Medicare & Medicaid Services in support of the agency’s proposal to refor
Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. Today, pharmacists are facing a health care environment that presents both opportunities and challenges.
CVS Health announced that Aetna, a CVS Health business, has entered into a four-year reinsurance arrangement with Vitality Re X Limited as part of its long-term capital management strategy.
For the second year, Hy-Vee, Inc. will be providing free biometric screenings throughout its eight-state region during Heart Health Month in February. Hy-Vee dietitians working out of Hy-Vee Healthy You Mobiles will offer the free biometric screenings to customers at 150 Hy-Vee stores.
CVS Pharmacy has expanded the responsibilities of Judy Sansone, the chain’s senior vice president of front store business and chief merchant. In addition, George Coleman has been promoted to senior vice president of merchandising, reporting to Sansone.
BD (Becton, Dickinson and Company), announced the U.S. Food and Drug Administration 510(k) clearance of its second generation BD Nano pen needle, designed for more reliable subcutaneous injection depth.
Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. Looking ahead to 2019, the pharmacy business is poised to be more disrupted than ever before.
Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application for Dofetilide Capsules, 0.125 mg, 0.25 mg, and 0.5 mg. Aurobindo’s dofetilide capsules are an AB-rated generic equivalent to the reference listed drug, Pfizer’s Tikosyn.
MORRISTOWN, N.J. – For the first time, Hoy Health makes it possible for consumers to purchase medications in the U.S for their loved ones in Latin America, and Hoy Health will home-deliver within 24 hours. Consumers can visit HoyRX.
DEERFIELD, Ill. – Walgreens has issued the following statement on announced settlement with U.S. Department of Justice and the Office of the Inspector General of the U.S. Department of Health and Human Services: “Walgreens is pleased to have resolved these matters with the Department of Justice.
Walgreens Boots Alliance has agreed to pay more than $269 million to settle federal and state lawsuits that accused the retailer of overbilling federal health-care programs. The pharmacy chain will pay $209.
Accordant, a CVS Health company, announced today that it has received Case Management Accreditation from NCQA for three years. This accreditation is awarded to organizations that demonstrate compliance with the rigorous Case Management Program standards.
Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. For much of 2018, capital markets for biotech investment were strong. Some 53 biotech companies went public with more than $5.
CutisPharma announced the commercial availability of First-Metoprolol grape-flavored oral solution compounding kit.
Benzer Pharmacy has hired accomplished retail pharmacy and health care technology expert Meghann Chilcott to lead future decision-making efforts as the company’s new chief technology and marketing officer.
CVS Health today was recognized by Fortune magazine as one of the World’s Most Admired Companies for the fifth consecutive year. CVS Health was honored as No. 35 on the annual rankings of the world’s most respected and reputable corporations, up four spots from 2018. The company was also ranked No.
